ALK licenses rights to neffy, an adrenaline nasal spray for emergency treatment of anaphylaxis Read more
Alkem signs agreement with US-based Sonnet BioTherapeutics to develop, commercialise its drug candidate for diabetic peripheral neuropathy in India Read more
Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India Read more